Zura Bio is a clinical-stage, multi-asset biotechnology company.
Zura Bio has raised $144.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in February 2026.
Zura Bio's investors include RA Capital Management, Great Point Partners, Deep Track Capital, Armistice Capital, Suvretta Capital Management.
Zura Bio is headquartered in Henderson, United States.
Zura Bio is a clinical-stage, multi-asset biotechnology company.
Zura Bio is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Zura Bio — Funding & Investors." VCBacked, February 25, 2026, https://www.vcbacked.co/company/zura-bio. Accessed September 3, 2026.
VCBacked. (2026). Zura Bio — Funding & Investors. Retrieved September 3, 2026, from https://www.vcbacked.co/company/zura-bio
{{cite web |title=Zura Bio — Funding & Investors |url=https://www.vcbacked.co/company/zura-bio |website=VCBacked |access-date=September 3, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated